CCOc1ccc(-c2n[nH]c3c2C(c2ccccc2OC)N(c2ccc(Br)cc2)C3=O)cc1
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?